Claims
- 1. A method of treating a patient with leukemia, comprising administering to said patient a chemotherapeutically effective amount of N-( 2-dimethylaminoethyl)-3-amino-1,8-naphthalimide.
- 2. The method of claim 1, wherein said N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide is in a pharmaceutically acceptable carrier.
- 3. The method of claim 1, wherein said effective amount is 1-64 mg/kg of body weight.
- 4. A method of treating a patient with p388 leukemia or L-1210 leukemia, comprising administering to said patient a chemotherapeutically effective amount for treatment of p388 leukemia or L-1210 leukemia of N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide.
- 5. The method of claim 4, wherein said N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide is in a pharmaceutically acceptable carrier.
- 6. The method of claim 4, wherein said effective amount is 1-64 mg/kg of body weight.
Parent Case Info
This application is a continuation of U.S. patent application Ser. No. 07/296,340, filed Jan. 9, 1989, now abandoned, which was a continuation of application Ser. No. 06/864,009, filed May 16, 1986, now abandoned, which was a continuation-in-part of application Ser. No. 06/533,542, filed Sep. 19, 1983, now abandoned.
US Referenced Citations (9)
Non-Patent Literature Citations (4)
Entry |
Fieser et al., "Reagents for Organic Synthesis", vol. 1, (1967), p. 440; John Wiley & Sons, N.Y. |
Drug Res., vol. 34, pp. 1243-1246 (1984), Paull et al. |
European J. of Med. Chem., vol. 16, pp. 207-212 (1981), Brana et al. |
Revista Espanola de Oncologia, vol. 29, pp. 439-444 (1982), Stockert et al. |
Continuations (2)
|
Number |
Date |
Country |
Parent |
296340 |
Jan 1989 |
|
Parent |
864009 |
May 1986 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
533542 |
Sep 1983 |
|